A detailed history of Gladius Capital Management LP transactions in Viatris Inc stock. As of the latest transaction made, Gladius Capital Management LP holds 2,655 shares of VTRS stock, worth $34,515. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,655
Previous 2,655 -0.0%
Holding current value
$34,515
Previous $30,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$10.32 - $12.13 $4,499 - $5,288
-436 Reduced 14.11%
2,655 $30,000
Q2 2024

Jul 18, 2024

BUY
$10.05 - $12.02 $1,165 - $1,394
116 Added 3.9%
3,091 $32,000
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $10,683 - $12,826
-948 Reduced 24.17%
2,975 $35,000
Q4 2023

Feb 07, 2024

BUY
$8.77 - $10.85 $9,848 - $12,184
1,123 Added 40.11%
3,923 $42,000
Q3 2023

Dec 18, 2023

SELL
$9.59 - $11.35 $7,278 - $8,614
-759 Reduced 21.33%
2,800 $27,000
Q3 2023

Oct 10, 2023

SELL
$9.59 - $11.35 $7,278 - $8,614
-759 Reduced 21.33%
2,800 $28,000
Q2 2023

Dec 18, 2023

BUY
$9.02 - $10.29 $6,846 - $7,810
759 Added 27.11%
3,559 $35,000
Q2 2023

Aug 08, 2023

BUY
$9.02 - $10.29 $5,402 - $6,163
599 Added 20.24%
3,559 $36,000
Q1 2023

Dec 18, 2023

BUY
$9.2 - $12.26 $1,472 - $1,961
160 Added 5.71%
2,960 $28,000
Q1 2023

May 09, 2023

SELL
$9.2 - $12.26 $4,213 - $5,615
-458 Reduced 13.4%
2,960 $29,000
Q4 2022

Dec 18, 2023

BUY
$8.72 - $11.56 $5,388 - $7,144
618 Added 22.07%
3,418 $38,000
Q4 2022

Feb 02, 2023

SELL
$8.72 - $11.56 $3,496 - $4,635
-401 Reduced 10.5%
3,418 $39,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $32,385 - $42,505
3,819 New
3,819 $33,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.